Pyrantel
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: pyrantel pamoate, pyrantel tartrate, pyrequan
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Pyrantel is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1974. DrugCentral lists 1 molecular target, including ACHE. Recorded indications include Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.
- Molecular targets: ACHE (1 listed in DrugCentral).
- Indications: Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.
- ATC code: P02CC01 (Tetrahydropyrimidine derivatives).
- Molecular formula: C11H14N2S; molecular weight 206.31 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Ascariasis
- Enterobiasis
- Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata
Off-label uses (5)
- Ancylostoma Duodenale Infection
- Infection by Moniliformis
- Infection by Uncinaria
- Necator Americanus Infection
- Trichostrongyliasis
Contraindications (1)
- Disease of liver
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Acetylcholinesterase | ACHE | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1974-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P02CC01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTHELMINTICS › ANTINEMATODAL AGENTS › Tetrahydropyrimidine derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Pyrantel is on its molecule page.
| Molecular formula | C11H14N2S |
|---|---|
| Molecular weight | 206.31 g/mol |
| CAS number | 15686-83-6 |
| InChIKey | YSAUAVHXTIETRK-AATRIKPKSA-N |
| PubChem CID | 708857 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Pyrantel used for?
DrugCentral lists the following indications for Pyrantel: Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.
How does Pyrantel work?
Its molecular targets in DrugCentral include ACHE.
When was Pyrantel first approved?
Pyrantel was first approved by the YEAR INTRODUCED in 1974.
What is the chemical formula of Pyrantel?
Pyrantel has the molecular formula C11H14N2S and a molecular weight of 206.31 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2999 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1585303 — compound record and bioactivity
- PubChem CID 708857 — chemical identifiers
- DrugBank DB11156 — drug record
- FDA UNII 4QIH0N49E7 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.